Cancer Family
Hepatobiliary Neoplasm
CI-CAN-00000198Explore in graph →
Non-malignant1,187 active trials17 approved drugs42 evidence items
- NCIt
- C8614
Loading cancer entity…
Cancer Family
CI-CAN-00000198Explore in graph →
Clinical trials
5,266 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02724332 | Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC | completed | Phase 1 | 300 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724345 | Postoperative Adjuvant TACE Treatment in CK18 Positive Patients | completed | — | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724358 | Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 | completed | N/A | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724436 | Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma | completed | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724475 | Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | completed | N/A | 180 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02102984 | Covered Versus Uncovered Biliary Stents for Biliary Malignancies | completed | N/A | 140 | Nuovo Ospedale Civile S.Agostino EstenseOTHER | 1 | Mar 30, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01692704 | Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy | completed | Phase 1 / Phase 2 | 12 | University of ZurichOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02210182 | A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma | completed | Phase 1 | 29 | Oncozyme Pharma Inc.INDUSTRY | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00877071 | LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed(HCC) | completed | Phase 2 | 2 | University of PittsburghOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00987935 | A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients | completed | Phase 2 | 134 | Boehringer IngelheimINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT01147380 | Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation(MIAMINK) | completed | Phase 1 | 18 | Seigo NishidaOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01466881 | Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 2 | Mar 10, 2016 | clinicaltrials |
| NCT02101593 | Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer | completed | Phase 1 | 8 | Polaris GroupINDUSTRY | 1 | Mar 4, 2016 | clinicaltrials |
| NCT00055692 | Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 29, 2016 | clinicaltrials |
| NCT01530503 | Second Line Therapy in Advanced Biliary Tract Cancer(BIT-2) | completed | Phase 2 | 52 | IRCCS San RaffaeleOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02447263 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer | completed | Phase 1 / Phase 2 | 87 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02449109 | Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Carcinoma | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT02687113 | Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion | completed | N/A | 240 | Seoul National University HospitalOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00774501 | The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy | completed | N/A | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01539681 | Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy(STELLA) | completed | — | 234 | BayerINDUSTRY | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01594125 | Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma | completed | Phase 1 | 30 | Boehringer IngelheimINDUSTRY | 1 | Feb 12, 2016 | clinicaltrials |
| NCT00732836 | Hepatic Arterial Infusion (HAI) of Abraxane | completed | Phase 1 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT01177631 | Proteomic Analysis of Human Hepatocellular Carcinoma | completed | N/A | 5 | Far Eastern Memorial HospitalOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT00919061 | Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02670265 | Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions(NUPAN) | completed | N/A | 100 | University Medicine GreifswaldOTHER | 0 | Feb 1, 2016 | clinicaltrials |
| NCT00003411 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT00109954 | Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 120 | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT01748721 | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Jan 8, 2016 | clinicaltrials |
| NCT00712790 | Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 35 | Singapore Clinical Research InstituteOTHER | 4 | Jan 6, 2016 | clinicaltrials |
| NCT02028845 | Loop-tipped Guidewire in Selective Biliary Cannulation | completed | N/A | 200 | Ajou University School of MedicineOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02552745 | Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization | completed | — | 200 | Sun Yat-sen UniversityOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT02613156 | Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma | completed | — | 25 | Sun Yat-sen UniversityOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib(REACH) | completed | Phase 3 | 565 | Eli Lilly and CompanyINDUSTRY | 27 | Dec 28, 2015 | clinicaltrials |
| NCT02156700 | Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors | completed | — | 196 | University Hospital DubravaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT01232296 | A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment | completed | Phase 2 | 162 | Novartis PharmaceuticalsINDUSTRY | 7 | Dec 4, 2015 | clinicaltrials |
| NCT00807300 | Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma(CEAL) | completed | Phase 2 | 77 | University of MagdeburgOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02008929 | to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)(MG4101) | completed | Phase 2 | 5 | Samsung Medical CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT01474694 | Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver(CALS) | completed | — | 14 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Nov 26, 2015 | clinicaltrials |
| NCT00024258 | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01506115 | Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma | completed | N/A | 11 | Samsung Medical CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00681499 | Quality of Life After Liver Resection | completed | — | 198 | University of BernOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT00980239 | HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | completed | Phase 1 | 115 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT02504957 | Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction | completed | N/A | 88 | Medical University of ViennaOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT01798160 | Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). | completed | Phase 4 | 24 | Johannes Gutenberg University MainzOTHER | 0 | Oct 20, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Mar 31, 2016source: clinicaltrials